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patients is associated with altered bak, bcl-xl,
and mcl-1 mRNA expression
Jisong Zhang2†, Jian He1†, Jingwen Xia1, Zhen Chen1 and Xiaodong Chen1*Abstract
Background: Delayed neutrophil apoptosis may be an important factor in the persistent inflammation associated
with chronic obstructive pulmonary disease (COPD). Bcl-2 family proteins are important regulators of neutrophil
apoptosis. We determined the mRNA levels of pro-apoptotic Bak and anti-aptototic Bcl-xl and Mcl-1 members of
the Bcl-2 family in unstimulated peripheral blood neutrophils from patients with mild to moderate COPD and
compared these to neutrophils from healthy controls.
Methods: Neutrophils were isolated from peripheral blood samples of 47 COPD patients (smokers: N = 24) and 47
healthy controls (smokers: N = 24). Percentages of apoptotic cells were determined at 4, 24, and 36 h for
unstimulated neutrophils cultured in vitro. Neutrophil mRNA expression of Bak, Bcl-xl, and Mcl-1 was determined by
real-time polymerase chain reaction (PCR). FEV1 (% predicted) and FVC were determined by spirometry and
correlations between mRNA levels and lung function parameters were determined.
Results: The percentages of apoptotic cells among unstimulated neutrophils from COPD patients were significantly
lower compared to cells from controls after 4, 24, and 36 h in culture; smoking history had only a minimal effect on
these differences. Unstimulated neutrophils from COPD patients had significantly lower Bak mRNA expression and
higher expressions of Bcl-xl and Mcl-1 mRNA than cells from healthy controls. Again, smoking history had only a
minimal effect on these trends. Bak mRNA expression was significantly positively correlated with both % predicted
FEV1 and the FEV1/FVC ratio, while Bcl-xl and Mcl-1 mRNA expressions were significantly negatively correlated with
%predicted FEV1 and the FEV1/FVC ratio.
Conclusions: The genes for pro-apoptotic Bak, and anti-apoptotic Bcl-xl and Mcl-1 may be important in regulating
the delayed neutrophil apoptosis observed in COPD, which may contribute to COPD pathogenesis.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1605269445677066
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Chronic obstructive pulmonary disease (COPD) is charac-
terized by irreversible airflow limitation [1]. COPD is also
characterized by an abnormal inflammatory response to
noxious gases, especially cigarette smoke, and these abnor-
mal inflammatory responses exacerbate airflow obstruction* Correspondence: xdchen8@hotmail.com
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reproduction in any medium, provided the or[2]. An inflammatory pulmonary infiltrate comprised pri-
marily of neutrophils is important in COPD pathogenesis.
Delayed cellular apoptosis can prolong the life of neutro-
phils and can lead to their accumulation, resulting in a per-
sistent inflammation in the lungs and airway, which is
considered to be a critical step in COPD pathogenesis [3].
Aggregation of neutrophils in the lungs and airway is
another characteristic of COPD [4-6].
Although a number of studies have confirmed the
delayed apoptosis of neutrophils in the peripheral circu-
lation, and in induced sputum and bronchoalveolarLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of COPD [7-10], the mechanisms underlying this
phenomenon are not clear. One report found no rela-
tionship between serum or sputum cytokines and the
rate of neutrophil apoptosis during COPD exacerbations
[11]. However, Brown et al. found that neutrophil apop-
tosis was reduced in both stable COPD subjects and in
healthy controls who were smokers, which might have
been attributed to the activation of NFκB [12].
Some genes may increase the risk of COPD develop-
ment in certain populations. Ning et al. found 6 genes
whose expressions were different in mild COPD patients
who were smokers and in smokers without lung injury
[13]. Thus, we hypothesized that delayed neutrophil
apoptosis was caused by differences in the expressions of
genes involved in the apoptotic regulatory pathway.
Members of the Bcl-2 protein family are part of the
mitochondrial intrinsic apoptotic pathway, and it has been
suggested that regulation of neutrophil apoptosis primarily
involves members of this family [14]. Human neutrophils
express many members of the Bcl-2 family, including the
pro-apoptotic proteins Bax, Bid, Bak, and Bad, and the
anti-apoptotic proteins Mcl-1, A1, and, Bcl-xl [15,16].
We hypothesized that a reason for the delayed neutro-
phil apoptosis observed in COPD is the abnormal
expression of Bcl-2 family members. For this study, we
selected genes for the pro-apoptotic protein Bak and the
anti-apoptotic proteins Bcl-xl and Mcl-1, as they have
been considered to be critical genes in regulating neu-
trophil apoptotic pathways [14,15]. We examined the
mRNA expressions of these genes in unstimulated
peripheral blood neutrophils from patients with mild to
moderate COPD and healthy volunteers to investigate
the relationship between Bcl-2 family gene regulation,
delayed neutrophil apoptosis, and COPD pathogenesis.
Methods
Subjects
All COPD patients in this study were in a stable stage
and were recruited from the out-patient clinic of our
hospital. These patients had mild-to-moderate COPD
(total: n = 47; smokers: n = 24). The categorization of
mild-to-moderate COPD was based on the Global Initia-
tive on Chronic Obstructive Lung Disease (GOLD)
criteria (http://www.goldcopd.org). Patients who were
possibly asthmatic were excluded based on the criteria
of the Global Initiative on Asthma (GINA; http://www.
ginaasthma.org).
We also recruited age-matched healthy controls (total:
n = 47; smokers: n = 24). For both COPD patients and
healthy controls, smoking history was recorded in pack-
years. Exclusion criteria for all subjects were history of
allergy, tuberculosis, neoplasm, asthma, thoracic or
abdominal surgery, or other serious concomitantdiseases. No subjects had had an infection of the respira-
tory tract for at least 3 months, and none were currently
being treated with antibiotics or steroids. The study was
approved by the ethics review committee of Huashan
Hospital, Fudan University and was conducted in
accordance with the Declaration of Helsinki and Good
Clinical Practice guidelines. All patients gave written
informed consent.
Lung function determinations
Lung function was determined in the Lung Function
Laboratory according to standard protocols using a
pneumotachograph (Jaeger MS Diffusion, Würzburg,
Germany). A subject breathed smoothly several times,
and then inspired forcibly until total lung capacity was
achieved. Subsequently, the subject expired forcibly until
reaching his/her residual capacity. Then, the subject
inspired until total lung capacity was achieved followed
by expiration. Results for the % predicted forced expira-
tory volume in one second (FEV1) and the forced vital
capacity (FVC) were generated automatically.
COPD patients were asked to stop taking long-acting
aminophylline 48 h or oral aminophylline 12 h before the
examination and stopped using any inhaled β−agonist 6 h
before the examination. If the FEV1/FVC was<70%,
patients were recommended to inhale salbutamol (Vento-
lin) (200 μg×2 puffs), and spirometry was repeated 15 min
later. An increase in FEV1/FVC of ≥12% and an absolute
increase of FEV1≥200 ml were regarded as positive for
bronchodilation.
Isolation of peripheral blood neutrophils
Neutrophils were isolated from peripheral blood sam-
ples collected in sterile heparinised tubes by a two-step
procedure. First, erythrocytes were removed by sedi-
mentation using dextran (T500, Pharmacia). Next,
granulocytes were isolated using discontinuous Percoll
gradient centrifugation [17]. We used 0.9% saline to
prepare 60% and 70% (by volume) Percoll solutions
(densities of 1.079 g/ml and 1.091 g/ml, respectively)
from a stock solution of 1.130 g/ml (100% fine grade
Percoll, Pharmacia). After centrifugation, the density of
peripheral blood granulocytes, primarily neutrophils, in
the Percoll solution was between 1.080 to 1.085 g/ml.
The isolated cells were determined to be > 98% neutro-
phils by Giemsa staining.
Neutrophil apoptosis assay
Neutrophils were suspended to a concentration of
5 × 105cells/ml in RPMI 1640 medium supplemented
with 10% FCS and 100 U/ml of penicillin-streptomycin,
and 200 μl of this suspension was pipetted into each well
of a 36 well flat-bottom microtest plate. Unstimulated
cells were cultured at 37°C in a 5% CO2 atm for 4, 24, or
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determined using previously described methods [18].
Briefly, after the indicated culture time, cells were
stained with a FITC-Annexin V antibody (Abcam) fol-
lowed by staining with propidium iodide (PI). After
washing in PBS, cells were evaluated by flow cytometry
using a FACScan (Becton-Dickinson, San Jose, CA). For-
ward and side scatter gates were set to evaluate neutro-
phils (granulocytes) only. The percent of cells that were
double-positive for Annexin V and PI were recorded as
percent apoptotic cells.
RNA extraction from neutrophils and reverse transcription
(RT)-PCR
Total RNA was extracted from neutrophils with RNAi-
soTMPlus (TaKaRa Biotechnology) and reverse tran-
scribed using PrimeScriptTM RT reagent kits (TaKaRa
Biotechnology). Reactions mixtures were 8 μL of total
RNA, 4 μL of 5×PrimeScriptTM Buffer, 1 μL of Prime-
ScriptTMRT Enzyme Mix I, 1 μL of oligo dT primer, 1 μL
of random primer, and 5 μL of RNase-free deionised H2O.
Real-time quantitative PCR
Neutrophils’ expressions of Bak, Bcl-xl, and Mcl-1 mRNA
were determined by real-time quantitative PCR [19]. Real-
time PCR used an Applied Biosystems 7500 Fast Real-
Time PCR System with glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as the internal control. The
gene sequences for Bak, Bcl-xl, Mcl-1, and GAPDH were
from the NCBI database (http://www.ncbi.nlm.nih.gov/).
Primer Express Version 3.0 (Applied Biosystems, America)
was used to design specific primers (details in Table 1).
SYBR Green Master Mix (Applied Biosystems, America)
was used for real-time PCR, with initial denaturation
at 95°C for 10 min, followed by 40 cycles at 95°C for 15 s,
60°C for 30 s, and 72°C for 30 s. An identical threshold
cycle (Ct) was used for each gene of interest. Relative
mRNA expression levels were determined according to
the 2-ΔΔCT method [20].
Statistical analysis
Results for subjects’ demographic and clinical characteris-
tics are given as means± standard deviations (SD) for con-
tinuous variables and n (%) for categorical variables.
Results for mRNA expression and apoptosis percentages
are given as means± standard errors of the mean (SEM).Table 1 Nucleotide primer sequences used for real-time quan
Target genes Nucleotide sequence
Bak 50— CCCAGGACACAGAGGAGGTTT—3050— GCCTCCTGTTCC
Bcl-xl 50— TGCGTGGAAAGCGTAGACAA—3050—ATTCAGGTAAGTG
Mcl-1 50— AGGCTGGGATGGGTTTGTG—3050—CACATTCCTGATGCC
GAPDH 50- AACAGCCTCAAGATCATCAGCA-3050- CATGAGTCCTTCCACFor continuous variables, groups were compared using a
two-sample t-test or a Mann–Whitney U test if data were
not normally distributed. A Pearson chi-square test was
used for categorical variables. Spearman correlation ana-
lysis was used to evaluate associations between mRNA
expression levels and lung function parameters. Statistical
significance was set at P < 0.05. Statistical analyses used
SPSS 15.0 software (SPSS, Inc, Chicago, IL, USA).
Results
Study subject characteristics
A total of 94 subjects were enrolled in this study. The
demographic and clinical characteristics of the healthy
controls (n = 47) and COPD patients (n = 47) are shown
in Table 2. There were more males than females (40 vs.
7 in each group), and the COPD patients were signifi-
cantly older, on average, than the controls
(61.3 ± 4.5 years vs. 58.8 ±4.6 years; P = 0.011). Slightly
more than 50% of the subjects were smokers in both
groups. Thirty (63.8%) COPD patients used inhaled short-
acting bronchodilators as needed and, among these
patients, 18 also used inhaled long-acting bronchodilators.
Neutrophil apoptosis
Apoptosis was determined for unstimulated neutrophils in
culture. Figure 1 shows the percentages of apoptotic per-
ipheral blood neutrophils from COPD patients and
healthy controls after different times in culture (4, 24, and
36 h.). Each subject group was also sub-divided into those
with smoking and non-smoking histories. Compared to
neutrophils from healthy controls, the percentages of
COPD patients’ apoptotic neutrophils were significantly
lower after culture for 4, 24, and 36 h. A smoking history
slightly increased the percent of COPD patients’ apoptotic
neutrophils, although the percent of apoptotic cells was
still lower than for cells from controls who smoked. These
results show that unstimulated neutrophils from COPD
patients have significantly delayed apoptosis relative to
neutrophils from healthy controls.
Neutrophil mRNA expression of apoptosis-related genes
Figure 2 shows the relative expressions of Bak, Bcl-xl,
and Mcl-1 mRNA’s by unstimulated peripheral blood
neutrophils that were analyzed using real-time PCR. In
neutrophils from COPD patients, Bak mRNA expression
was significantly reduced and the expressions of Bcl-xltitative PCR
Orientation Amplicon length Accession No.
TGCTGATG—30 SenseAntisense 65 bp NM001188
GCCATCCAA—30 SenseAntisense 75 bp NM138578
ACCTTCT—30 SenseAntisense 65 bp NM021960
GATACCA-30 SenseAntisense 102 bp M33197
Table 2 Subjects’ demographic and clinical characteristics
Variables Healthy controls (n = 47) COPD patients (n = 47) P-value
Age (years) † 58.8 ± 4.6 61.3 ± 4.5 0.011*
Sex{ 1.000
Males 40 (85.1%) 40 (85.1%)
Females 7 (14.9%) 7 (14.9%)
Smokers{ 24 (51.1%) 24 (51.1%) 1.000
Smoking history (pack/year) } 31.9 ± 7.4 31.7 ± 6.0 0.755
FEV1/FVC %
†, } 86.6 ± 4.5 56.8 ± 5.3 <.001*
FEV1,% Reference
†, } 103.1 ± 9.5 59.4 ± 6.3 <.001*
ISAB as needed{ 0 (0) 30 (63.8) -
ILAB regularly{ 0 (0) 18 (38.3) -
Abbreviations: COPD: chronic obstructive pulmonary disease; ISAB: inhaled short-acting bronchodilators; ILAB: inhaled long-acting bronchodilators.
†,{,} Results are means ± SDs for †,}continuous variables and n (%) for {categorical variables.
†{} Groups were compared using †two-sample t-test or }Mann–Whitney U test if data were not normally distributed. {Pearson Chi-square test was used for
categorical variables.
* P < 0.05, significantly different between groups.
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pared to neutrophils from controls. As with neutrophil
apoptosis, a history of smoking had an effect on mRNA
expression; however, these differences between mRNA
expressions remained significantly different between
COPD patients and controls regardless of smoking his-
tory. In COPD patients’ neutrophils, mRNA expression
for the two anti-apoptotic genes, Bcl-xl and Mcl-1, was
almost twice that of controls (Bcl-xl: 2.1 ± 0.3 vs.
1.0 ± 0.2; Mcl-1: 2.0 ± 0.4 vs. 1.0 ± 0.3; both P < 0.001).Figure 1 Comparisons of percentages of apoptotic neutrophils from
were isolated from healthy controls and COPD patients; these groups were
described in Methods, unstimulated peripheral blood neutrophils were cult
cells was determined. Results are means ± SEMs for: COPD/smokers (n = 24)
non-smokers (n = 23). Group comparisons were by Mann–Whitney U test. *
(p < 0.05); † significant difference as compared with Healthy/smokers (p < 0
(p < 0.05).Lung function and neutrophil mRNA expression of
apoptosis-related genes
As shown in Table 2, spirometric lung function para-
meters were significantly worse for COPD patients than
for healthy controls, including % predicted FEV1 and the
FEV1/FVC ratio. We used Spearman correlation analysis
to determine if these lung function parameters were asso-
ciated with neutrophils’ mRNA expression of apoptosis-
related genes. Figure 3 shows the correlations between the
mRNA expression levels for Bak (Figure 3A), Bcl-xlhealthy controls and COPD patients. Peripheral blood neutrophils
sub-divided into those with and without smoking histories. As
ured in vitro for 4, 24, or 36 h, after which the percent of apoptotic
; COPD/non-smokers (n = 23); Healthy/smokers (n = 24); and Healthy/
significant difference as compared with Healthy/non-smokers
.05); { significant difference as compared with COPD/non-smokers
Figure 2 Expression of Bak, Bcl-xl, and Mcl-1 mRNA’s in peripheral blood neutrophils. Real-time PCR was used to determine the expression
of (A) Bak, (B) Bcl-xl, and (C) Mcl-1 mRNAs in peripheral blood neutrophils. The ΔΔCt value for each mRNA was normalized to the value of the
GADPH housekeeping gene mRNA. Results are means ± SEMs for: COPD/smokers (n = 24); COPD/non-smokers (n = 23); Healthy/smokers (n = 24);
and Healthy/non-smokers (n = 23). Groups were compared using two-sample t-test for Bak and Mcl-1 mRNA’s, and a Mann–Whitney U test for
Bcl-x1 mRNA due to its non-normal distribution. * significant difference as compared with Healthy/non-smokers (p < 0.05); † significant difference
as compared with Healthy/smokers (p < 0.05).
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These correlation results were not affected by smoking
status (data not shown); thus, these correlations are shown
by COPD status only without stratifying according to
smoking status. Bak mRNA levels were significantly posi-
tively correlated with lung function parameters, and Bcl-xl
and Mcl-2 mRNA levels were significantly negatively cor-
related with lung function parameters.
Discussion
The aim of this study was to investigate whether changes
in gene expressions for members of the Bcl-2 family of
pro- and anti-apoptotic proteins were involved in the
delayed neutrophil apoptosis seen in COPD. We found
that, in peripheral blood neutrophils from subjects with
stable mild to moderate COPD, mRNA expressions for
two anti-apoptotic genes (Bcl-xl and Mcl-1) were upre-
gulated and that for a pro-apoptotic gene (Bak) was
downregulated (Figure 2). Our findings showed that the
abnormal expression of Bcl-2 family member genes was
present in an early stage COPD and that this trend of
abnormal gene expression was consistent with the
delayed apoptosis seen in neutrophils from COPD
patients (Figure 1). We also found that these mRNA
expression levels were significantly correlated with lung
function parameters (Figure 3).
In our study, after 36 h in unstimulated culture, the
apoptosis rate of peripheral blood neutrophils of COPD
patients was significantly delayed relative to neutrophilsfrom healthy controls. For peripheral blood neutrophils,
others have reported decreased apoptosis during COPD
exacerbations, but not in stable COPD [8,9]. Using cells
from sputum samples, neutrophil apoptosis for COPD
patients who were current smokers was reported to be
only one-third of that seen in sputum samples from
healthy non-smokers.12 This difference in results be-
tween neutrophils from peripheral blood and sputum is
presumably due to the additional effect on sputum neu-
trophils of the chronic inflammation present in the lungs
of COPD patients, particularly those who smoke.
In our study, the differences between COPD patients and
controls in neutrophil mRNA levels of Bcl-2 family genes
were greater than the differences seen in the percentages of
apoptotic neutrophils. The mRNA levels for the two anti-
apoptotic genes (Bcl-xl and Mcl-1) were twice as high as in
controls, and the mRNA level of the pro-apoptotic gene
(Bak) was 60% of that in controls’ neutrophils.
The Bcl family contains pro- and anti-apoptotic proteins
that are found in the outer membranes of mitochondria.
The balance between the pro- and anti-apoptotic mem-
bers of this family is the central factor in the opening and
closing of permeability transition (PT) pores [21], which is
a critical pathway for cytochrome c release from mito-
chondria [22] and causes apoptosis by activating caspase-
9. The increase in anti-apoptotic mRNA expression and
decrease in pro-apoptotic mRNA expression seen in our
study could tip the balance toward neutrophil survival and
decrease the apoptosis rate.
Figure 3 (See legend on next page.)
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Figure 3 Correlations between mRNA levels of Bak, Bcl-xl, and Mcl-1 and lung function parameters. COPD patients are represented by
solid circles and healthy controls by open circles (N = 47 for each group) Spearman correlation analysis was used to assess associations between
variables. (A) Bak mRNA level was positively correlated with lung function. FEV1/FVC%: r = 0.72; P < 0.001; FEV1% reference: r = 0.70; P < 0.001. (B)
Bcl-xl mRNA level was negatively correlated with lung function. FEV1/FVC%: r = -0.82; P < 0.001; FEV1% reference: r = -0.86; P < 0.001. (C) Mcl-1
mRNA level was negatively correlated with lung function. FEV1/FVC%: r = -0.79; P < 0.001; FEV1% reference: r = -0.79; P < 0.001.
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teins, rather than their mRNA expression, that would ul-
timately regulate apoptosis, and protein levels do not
always correspond to mRNA levels. This was reportedly the
case for Bcl-xL. Moulding et al. [15], who studied peripheral
blood neutrophils from normal subjects, detected Bcl-xL
mRNA in these cells, but could not detect the correspond-
ing protein. They also found that blocking gene transcrip-
tion with actinomycin decreased Mcl-1 mRNA and protein,
but had virtually no effect on Bcl-xL mRNA levels. There-
fore, Bcl-xL may not be involved in the control of apoptosis
in human neutrophils.
Although gene transcription is important in determining
mRNA levels, the mRNA half-life is also important. The
half-life of the mRNA for Mcl-1, an anti-apoptotic protein,
is relatively short and the half-life of the mRNA for Bak, a
pro-apoptotic protein, is relatively long [15]. Thus, Mcl-1,
whose mRNA levels can change relatively rapidly, might
be more important than Bak in the short-term control of
apoptosis. A relationship between decreased Mcl-1 mRNA
expression and an increase in neutrophil apoptosis has
previously been reported for patients with sepsis [23], but
until now, research on COPD patients has been lacking.
We found only minimal differences in Bcl-2 family
mRNA expression between healthy smokers and healthy
non-smokers, and between smoking and non-smoking
COPD patients. This suggests that the effects of smoking
are not evident in neutrophils from peripheral blood as
would be expected in cells from BALF, especially in patients
with mild to moderate COPD like those included in the
current study. An alternative explanation would be that
Bcl-2 member expression is implicated in COPD pathogen-
esis, but not through a pathway that is affected by smoking.
In addition, COPD is the result of the interactions between
genes and the environment [24,25]. Genes other than Bcl-2
family members could be affected by these factors.
More studies are needed to investigate the relationships
between mRNA and protein levels, and to determine
whether the results of Bcl family members in normal neu-
trophils apply to COPD patients. An in-depth study is also
needed on the neutrophil apoptosis pathways that are
influenced by cigarette smoking and the complex effects
of nicotine on neutrophil apoptosis in vivo.
Conclusions
We evaluated associations between Bcl-2 family mem-
bers mRNA expressions and delayed apoptosis forunstimulated peripheral blood neutrophils from COPD
patients. Relative to neutrophils from healthy controls,
pro-apoptotic gene Bak mRNA was significantly down-
regulated in COPD patients’ neutrophils, whereas
anti-apoptotic gene Bcl-xl and Mcl-1 mRNA’s were sig-
nificantly upregulated. In addition, Bak mRNA was sig-
nificantly positively correlated with %predicted FEV1
and the FEV1/FVC ratio, while Bcl-xl and Mcl-1
mRNA’s were negatively correlated with these para-
meters. The trend for abnormal mRNA expression for
members of the Bcl-2 family was consistent with the de-
cline in lung function in COPD. Therefore, the most
likely neutrophil apoptosis pathway in COPD patients
may be the mitochondrial pathway, which could be a
new target for future COPD research.
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